What question did this study set out to answer?

To examine trends in medication treatment for opioid use disorder and evaluate quality-of-care indicators among Medicaid enrollees across multiple US states.

July 13, 2021JAMAOpen Access

Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018

View Full Paper

Ask AI

Bookmark

To examine trends in medication treatment for opioid use disorder and evaluate quality-of-care indicators among Medicaid enrollees across multiple US states.
Serial cross-sectional study of 1,024,301 Medicaid enrollees aged 12 to 64 years with opioid use disorder diagnoses across 11 US states from 2014 through 2018.
State-level generalized estimating equations evaluated associations between enrollee characteristics and outcomes, with random-effects meta-analyses applied to generate pooled global estimates.
Pooled prevalence of enrollees receiving medication for opioid use disorder increased from 47.8% (state range, 35.3%-74.5%) in 2014 to 57.1% (state range, 45.7%-71.7%) in 2018, whereas 180-day continuous medication prevalence did not significantly change (prevalence difference, -0.01; 95% CI, -0.03 to 0.02).
Non-Hispanic Black enrollees experienced significantly lower medication use than White enrollees (prevalence ratio [PR], 0.72; 95% CI, 0.64-0.81; P < .001).
Pregnant enrollees had significantly higher rates of medication use (PR, 1.18; 95% CI, 1.11-1.25; P < .001) and 180-day medication continuity (PR, 1.14; 95% CI, 1.10-1.17; P < .001) compared with other eligibility groups.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Serial cross-sectional study reveals increased medication treatment for opioid use disorder among Medicaid enrollees, indicating persistent racial disparities and stagnant treatment continuity.

Cite This Study

Brown et al. (2021) studied this question.

synapsesocial.com/papers/6a7194adf44fa9f079df5a1e https://doi.org/10.1001/jama.2021.7374

View Full Paper

Ask AI

Bookmark

Implication

Serial cross-sectional study reveals increased medication treatment for opioid use disorder among Medicaid enrollees, indicating persistent racial disparities and stagnant treatment continuity.

Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018

Key Points

Discussion

Implication

Cite This Study

Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider